St. Jude Medical Announces First Implant Evaluating New Size of Portico Heart Valve in Ongoing European Clinical Trial
08:00 EST 4 Feb 2013 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company,
today announced the first patient implant of its 25 mm Portico™
Transcatheter Aortic Heart Valve using the Transfemoral Delivery
System in its ongoing Europea...
Other Sources for this Article
St. Jude Medical, Inc.
J.C. Weigelt, 651-756-4347
Investor
Relations
jweigelt@sjm.com
or
Sarah
Shamla, 651-756-6293
Media Relations
sshamla@sjm.com
More From BioPortfolio on "St. Jude Medical Announces First Implant Evaluating New Size of Portico Heart Valve in Ongoing European Clinical Trial"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
